Verbio SE (VBK) Earnings Call Transcript & Summary
November 12, 2026
Earnings Call Speaker Segments
Claus Sauter
executiveThanks so much. And thanks, everyone, for being with us today. Olaf and I will walk you through the results for our first quarter — we got off to a strong start this year, with underlying profitability up substantially and positive cash flow. Given how the first quarter beat expectations and with Biodiesel spreads staying strong across Europe and North America, we now anticipate EBITDA for our business year 2026 and 2027 landing at the top end of the guidance range of EUR 210 million to EUR 250 million. We're also seeing meaningful movement on the regulatory front. Germany is cracking down harder on biofuels that are falsely declared. That's a boost for compliant producers such as Verbio and makes the competitive landscape better. I'll begin with the headline numbers for the first quarter. Overall, production trended positively. Biodiesel output rose to 179,000 tonnes in the first quarter; production was higher in Europe and rose even more strongly in Canada. Biomethane output likewise grew, reaching 359 gigawatt hours. Bioethanol production came in slightly below the prior year at 147,000 tonnes; the main reason was weaker output in Europe, where yields were lower and we hit some technical problems over the summer. EBITDA climbed sharply to EUR 76.1 million, up from EUR 15.4 million in Q1 of last year. The main drivers were improved margins in biodiesel and bioethanol in Europe, the robust performance of our biodiesel operations in Canada and a larger contribution from the greenhouse gas quota business; we also recorded a clear gain in cash flow, with operating cash flow moving from minus EUR 17.3 million in last year's same quarter to positive EUR 34.1 million. Investments, meanwhile, held roughly flat at about EUR 20 million. That's chiefly tied to our specialty chemicals project in Bitterfeld, biogas production in South Bend and efficiency initiatives. In Bitterfeld, the ethenolysis plant continues its ramp-up. All of this produced positive free cash flow of EUR 13.5 million, versus minus EUR 37.8 million a year earlier. That positive free cash flow also helped bring net debt down from EUR 91.5 million at the close of June to EUR 83.1 million at the close of September. Our equity ratio stayed very solid at 60%. With that, I'll pass things to Olaf, who will take you through the EBITDA development management and each of the segments in greater detail.
Olaf Troeber
executiveThank you, Claus. Good morning, good afternoon, and good evening to all of you. I appreciate everyone joining us for today's presentation of our financial results. I should apologize — my camera is having a few technical problems. So yes, I'm hoping we can get that sorted out in the next few minutes. Now, going back, let me place the first quarter EBITDA in context against the fourth quarter. Reported EBITDA in Q4 came in at EUR 88 million, versus EUR 76 million in the first quarter. As a general reminder, Q4 contained the EUR 19.1 million positive valuation effect in the biomethane business that's shown here. So if we strip out that effect, Q4 EBITDA was in fact EUR 69.1 million; therefore, on an underlying basis, group EBITDA rose quarter-on-quarter, which is genuinely good news. Turning to the segments, biodiesel went up from EUR 32 million to EUR 51 million, whereas bioethanol and biomethane fell from EUR 55 million to EUR 19 million, again largely mirroring the valuation effect I just referred to. And lastly, the other segment also improved, both year-on-year and quarter-on-quarter. That improvement came mainly from a positive contribution out of our trading activities. Now let me walk you through each of the individual segments in more detail. We'll begin with biodiesel. Production came in slightly above Q4 '25, '26, with the increase originating in Canada. Sales amounted to EUR 306 million against EUR 280 million in Q4, mainly reflecting higher biodiesel prices. EBITDA rose from EUR 32 million to EUR 51 million, and the key driver there was the strong margin environment. Higher biodiesel prices more than offset higher feedstock costs. At the same time, we gained from feedstock purchases made below the market prices seen during the quarter, which let us realize market actions even above market spreads. All in all, the positive development of our Canadian biodiesel business added to the improvement as well; for some market context, let's now turn to the reference charts. These charts show how biodiesel market spreads developed in Europe. The spread is — the spread itself is simply the gap between biodiesel and rapeseed oil prices. It doesn't reflect our specific sourcing, but it does give you a good indication of how the overall market developed. Following the very weak levels at the end of Q4 last financial year, spreads recovered strongly over the first quarter. The chart on the right shows what drove this. Biodiesel prices rose significantly during the quarter, while rapeseed oil prices softened somewhat as the quarter progressed. That said, the quarterly average for rapeseed oil was still higher, both quarter-on-quarter and year-on-year. Now on the biodiesel side, we had supportive factors on both the demand side and the supply side. On the demand side, the upcoming window — citizens supported demand for received material Easter, or as we call it RME, thanks to its better cold flow properties. RME is part of the same plant shown on the slide. When it comes to supply, low water levels along the Rhine held back rapeseed crushing, and rapeseed supply out of Ukraine stayed constrained as well. Both of those factors restricted feedstock availability for RME production, which kept supply tight and gave biodiesel prices additional support. All in all, the market environment got considerably better over the quarter, as the chart displays or shows. As I noted on the prior slide, our realized margins actually exceeded those market spreads, thanks to our feedstock sourcing. Let's turn now to the second segment, bioethanol and biomethane. Versus Q4, bioethanol output fell to 147,000 tonnes, largely because of reduced production in North America, where we experienced some temporary production issues over the quarter. Biomethane production slipped somewhat from the record level seen in Q4, landing at 359 gigawatt hours. Revenue dropped from EUR 1,243 million to EUR 221 million, chiefly reflecting the smaller contribution from North America. EBITDA likewise declined from EUR 85 million to EUR 19 million. Once more, we should remember that Q4 contained the EUR 19 million positive valuation effect in the biomethane business. On top of that, bioethanol market margins in Europe were below the exceptionally strong levels recorded in Q4. Still, true to our sourcing approach, we managed to contain the effect of rising market grain prices. Our actual feedstock costs thus rose far less than the market price movement such as — now in North America, realized margins improved even though ethanol crush cash was less favorable, mostly driven by higher cone values. That offset the effect of reduced production and sales volumes. Let's now examine the overall market development. Turning to the greenhouse gas quota market that we cover, Q4 conditions carried into the first quarter. Demand progressively moved toward the 2026 compliance year, and prices during the quarter stayed strong at roughly EUR 500, EUR 510 per tonne CO2 equivalent. Part of that higher level relative to last year mirrors the rule of double accounting. Yet even after adjusting for that effect, quota prices are plainly at the levels seen a year ago. This also shows up in the larger year-on-year contribution from the Greenhouse Gas quota business. The market itself keeps gaining from a tighter supply and demand balance after RED III was implemented. Here too, low water levels on the Rhine lent extra support, since difficult and expensive logistics made physical compliance harbor for some market participants, particularly market participants along the river Rhine. Since the quarter ended and with the annual tender season beginning, quota prices have come under some pressure. So we stay cautious about how prices will develop going forward. Let's proceed to the European bioethanol market. As the left side shows, market spreads declined over the first quarter from the high levels recorded at the close of Q4. The chart on the right illustrates what drove this. At first, ethanol prices went down, whereas wheat prices rose during the quarter. Regarding ethanol, the market softened because the import arbitrage had reopened. Meanwhile, low water levels on the Rhine limited product movement out of the Rotterdam region. That caused inventories to build up and placed extra pressure on ethanol prices. Near the end of the quarter, ethanol prices bounced back, partly because of higher natural gas prices and increasing production costs for the industry; so although ethanol prices climbed, that did not represent the same improvement for merchants — once again, production costs went up. On Ukraine, international prices found support from ongoing logistic constraints tied to the war in Ukraine and some improved related crop losses, particularly in cone; however, this benchmark development does not completely reflect our sourcing situation in our relevant sourcing regions, especially Eastern Germany and Poland, where overall grain availability stayed good. We also observed high availability of lower grain, a lower quality grain, that we can use in our production and that trades at discounts to benchmark prices. So although benchmark market spreads were lower than in Q4, our actual feedstock costs developed much better than the market benchmark would such as — now turning to the U.S.
Olaf Troeber
executiveEthanol output stayed elevated through the quarter, yet demand held up well too. Domestic blending got a lift from stronger D6 RIN values — those are the credits companies use to comply with the U.S. renewable fuel standard — and those firmer values gave an incentive to blend more ethanol. Along with export demand, that helped soak up the heavy production and lent support to ethanol prices; turning now to feedstock costs for the corn harvest in '25. Corn gathered last year also climbed during the quarter, backed by robust demand from exports, feed and ethanol output. Since corn prices climbed more sharply than ethanol prices, the benchmark spread on the left side of the slide came under pressure. Looking forward, the most recent crop estimator figures for the '26 harvest — the one underway right now — indicate strong yields and ample corn supply. That is already weighing somewhat on corn prices and ought to help U.S. ethanol exports; for us, firmer corn values gave added support in the quarter. Even with thinner ethanol margins, our realized overall margins were better both versus a year ago and versus the prior quarter. Moving to the full financial year. With the first quarter beating expectations and biodiesel spreads staying strong in Europe and North America, we now anticipate group EBITDA landing at the top of our guidance range of EUR 210 million to EUR 250 million. Our view on how the business moves through the seasons is unchanged. Consequently, first quarter performance shouldn't be taken as indicative of the full year run rate. We still expect a meaningful contribution from the greenhouse gas quota business. Right now, quota prices face some pressure amid the ongoing tender season. So we stay cautious on that front. On cash flow, it developed quite positively; stronger earnings together with the planned lower level of investments should underpin strong cash generation and a further significant cut in net debt. With that, I'll hand back to Claus for a few remarks on the latest market and regulatory developments. Thank you.
Claus Sauter
executiveThank you, Olaf. Let's spend a bit of time on the regional market and what's happening on the regulatory side. In our key markets we're seeing quite a few favorable developments — actually, I'd go so far as to say they're only positive. In Germany, at last, there's firmer action being taken against fraud in the biofuel market. Keep in mind that the raunutz is going away in January 2027. So this year was a special situation for us. In any case, under the new rules, fuels carrying fraudulent sustainability documents can be kept out of the greenhouse gas quota system starting January 2027; that's good news for producers such as us, such as Verbio. Customers — and this is what we're seeing in the negotiations currently underway — are searching more intently than before for dependable partners whose supply chains are compliant. That can underpin demand and possibly lead to improved commercial terms as well. Over in Europe, the debate about the post-2035 framework is getting more concrete. A compromise has been agreed by the center groups in the European Parliament. It was adopted by the Environment Committee last week, with the plenary vote anticipated in December. Under the proposal, VEEF vehicles running solely on eligible renewable fuels are recognized as zero emission vehicles. Plainly, the combustion engine isn't the problem. The fuel is the problem. And I've been saying this now for more than 10 years. It isn't the combustion engine that's the problem. It's the fuel. So when fossil fuels are replaced with renewable molecules, we have a solution. It's available today; it saves costs and works with the existing infrastructure that we already have; we're also seeing mounting support for E20 and B10. Either of them would let more renewable fuels be used in the vehicle fleet that's already on the road. So the notion of going all electric is gradually fading; and judging by the data we have, registrations of CNG and LNG trucks have picked up lately. That's an encouraging signal for biomethane demand in heavy-duty transport; and finally, this is what we expected, particularly once the war began in March, because the gap between fossil diesel and CNG, bio-CNG and bio-LNG in a truck is significant, and it comes to about 1/3 of the price compared with fossil diesel; in the U.S., strong biodiesel margins have let us alter our plans for our Canadian plant in Welland. Rather than the winter shutdown originally planned, we're able to keep producing through the winter for the most part. And the proposed Canadian CFR multiplier for domestic production could offer further upside for Welland. On the whole, we see the market and the regulatory environment heading in the right direction. There's one more point I wanted to touch on, and that's the role played by fossil fuel prices; sometimes we see our share price move sharply along with the oil price. So let me be crystal clear about the relationship here. Several of the developments we've just discussed are reinforced by worries about energy security and by higher fossil fuel prices. That said, it doesn't mean our profits just track the oil price. While oil was high, it helped our business model, since at present every one of our molecules—biodiesel, bioethanol and biomethane, renewable natural gas—costs less than its fossil counterpart; so high oil prices were a support in that situation. Without diesel at EUR 2.50, I don't think we'd be discussing E10 and B10. So it was supportive. But that has led us to the ideological shift. Biofuels have markets of their own. Their prices rest on supply and demand and are tightly tied to the markets for their feedstocks, the agricultural markets. They don't merely track the oil price. We then gain added value from greenhouse gas quotas in Europe and other carbon incentives. Added value also comes from co-products. Corn oil in our U.S. ethanol business is a good example, as we have just seen. And then there is the role of glycerine and, in the future, chemicals. On the cost side, feedstock and energy prices are key. And finally, our sourcing, plant utilization and where and when we sell our products all shape the margin we achieve. So the message is simple. High fossil fuel prices will support demand for biofuels, but they do not directly determine Verbio's margin or EBITDA. With that, let's move to Q&A.
Jorge Gonzalez
analystThe first topic I'd like to raise is GHG quotas. You've seen the price recently trading between EUR 500 and EUR 510. Yet you mentioned at the same time that the price is currently facing some pressure. Could you tell us where the price sits right now and how your negotiations with customers are progressing on the GHG quota front?
Claus Sauter
executiveWell, yes, as Olaf mentioned, quota prices have fallen since we're in the negotiation phase at the moment. So, as I said in my speech, our customers' focus is shifting increasingly toward compliance, security of supply, and resilience. At the moment, activity in the market is fairly limited. We observe this pattern annually: during this period, quota prices decline. However, talks are still underway, so few contracts have been signed as of now, which means I can't provide a genuine outlook. We anticipate that next year all of our production will be required, since everything tied to palm — and pume as well — is no longer counted in 2027. There's no double counting. As a result, rapeseed oil should stay strong. Few alternatives exist. Those are the primary points being discussed in the negotiations right now, but it's too soon. We can't offer you much feedback on this yet. Moving on to 2027, you'll notice the obligation rises 5.5%, taking it from EUR 12 million up to EUR 17.5 million. The frozen CO2 savings from '24 are also going to reach the market. In any case, we anticipate solid quota prices — though perhaps not at those peak levels. We don't expect EUR 500 or EUR 510, but we do believe quota prices will definitely land somewhere in the EUR 400 to EUR 500 range.
Jorge Gonzalez
analystThat's quite useful. I have one question about the inventory increase in your P&L. Does it also tie to GHG quotas that were generated this quarter and that you'll sell at a later point? Yes, sorry, on this one, are you — have you altered the way you account for them, internal cost or something like that.
Claus Sauter
executiveNo. Jorge, thanks for asking. Actually, that's more driven by volume. It's partly the quota — a rise in quota inventory — and also a fraction offices had higher volumes in biomethane; so that's actually pretty natural, since you buy and sell the biomethane; so there's fluctuation between the inventory and with respect to the quota itself. As you know, most of the quota gets sold in March, April of the following year. So an increase will occur even over the course of the next quarter.
Olaf Troeber
executiveJorge, right now the focus is that they want to make — they need to get a sense of what things will look like in 2027. So at present, the main priority is locking in the new volumes for 2027. And the changes — the regulatory changes are significant. So once that is complete, they review how much fossil fuel they sold and after that they put together their CO2 balance sheet, usually in Q1; during the last few years, it was also pushed back to Q2. So by the end of March or June at the latest, they have to be compliant. So the focus right now is mainly on getting their hands on the molecules for next year. And in particular, that was a very interesting year — the low water in the Rhine also demonstrated how important it is to have local supply, because all the inputs usually come from Rotterdam on the Rhine; and when there is no water, then logistics is also a key issue. So that really was a very, very interesting year.
Jorge Gonzalez
analystOne final question; regarding Bioethanol, you said strong ethanol demand along with solid corn output might perhaps turn those negative rates around — is that what you intend to convey through your methods? Were you hinting that the spread is leveling off? Is this...
Olaf Troeber
executiveYou mean the U.S.
Jorge Gonzalez
analystWithin the U.S., that's right.
Olaf Troeber
executiveIf we had the ability to predict what those margins would be...
Claus Sauter
executiveThe way we see it, demand for ethanol around the world keeps rising, and U.S. corn ethanol is the least expensive molecule out there. In the past I would say the problem with ethanol remained that people don't regard it as renewable liquid energy. A lot of ethanol output is viewed as a way to keep the local farmer happy, yet that perception is fading because oil prices are high; we clearly saw this happen in 2026. We initially anticipated that in '27 worldwide ethanol demand would increase, since it is a cheap input. It assists in pushing fossil prices lower. And on that note, '26 was already quite strong on margins. On top of that, there's the 45C and all of that. So we expect at minimum that margins will remain at that level, though in my view there is upside potential as well.
Claus Sauter
executiveNo, I do — what we said at the CMD hasn't changed, or didn't change. And what was the first question?
Claus Sauter
executiveTo start, our hedging strategy isn't something we disclose. That said, we've gained visibility, particularly on biodiesel. And yes, as I attempted to lay out earlier, certain feedstocks are leaving the market — anything tied to palm oil. Rapeseed oil will therefore rank among the most important feedstocks, above all for crop based. And we're fairly optimistic about carrying on what biodiesel means for the second quarter as well.
Claus Sauter
executiveOkay, so the primary goal for us is to raise utilization, which means we aren’t focused on and have no new projects for constructing new plants. There’s still — as you saw in the presentation, there’s room to increase production. And at the moment, we have a very interesting situation because natural gas prices have tripled, so we need to watch how the impact will play out. Right now, our main focus is bringing our RNG into the transport sector. There, we need more trucks, because one reason natural gas, bio-LNG, and bioenergy are so cheap compared with diesel is that we don’t have enough trucks — I mentioned this. We need more trucks, and then we can make better use of our filling stations. And I think there’s also an opportunity here to raise the margin. But we have to see what the next months bring either way here, even if oil prices and natural gas prices are coming down. We will see this positive impact because the products we bought in recent months, LNG and CNG trucks, are still not on the road; they are coming, and from what we heard from the producers, most of them are all sold. So here, a lot of demand is shifting away from diesel to CNG and LNG.
Olaf Troeber
executiveFrom an accounting and technical standpoint as well, splitting bioethanol apart from the biomethane segment really doesn't make sense, since it's all one process. The biomethane gets produced, and as we see it, that biomethane production will subsequently go into making biomethane; so really it's just a matter of transfer pricing. And yes, separating these bioethanol and biomethane segments doesn't make sense.
Claus Sauter
executiveOkay, that one is quite straightforward to respond to. The guidance exists, though the final version won't arrive until December. Until we truly have everything documented, we're unable to factor anything into our guidance. Something will be included, but we must hold off until we possess the truly final guidance; and it isn't just 45C affecting production — the climate smart act also comes into play, where carbon intensity depends on how the farmers operate, or on the amount of fertilizer, fossil fertilizer, they apply to grow their corn. So the impact is considerable. As things stand, it will be December before that happens, and at that point I believe we can revise our guidance once we know precisely how much we are able to take into account.
Claus Sauter
executiveWe spent the entire summer working on these issues. That involved both sides, something in the biogas production that we hadn't seen, something we never saw at our German plant, but we've fixed it now. So we worked all summer long, and we're very optimistic that we'll now be able to ramp up both plants and increase production. And yes, get more volumes. We fixed it.
Claus Sauter
executiveSo, two weeks back, I spent 1 week in India. The Indian market has a lot of dynamism right now. There's a new program involving CapEx subsidies, and the price for what they call CBG, compressed biogas, in India has gone up by 40%. That's quite interesting. There's also an obligation on state-owned companies to build several companies altogether, up to 200 plants. You know we've announced a joint venture with GAIL, which is the grid operator. So I think we clearly waited for the new regime, and now we're continuing to get our JV, our joint venture, in place. And yes, I'd guess a lot of investment will be going now into new plants and more production capacity. We still have one plant in India, which remains the biggest plant; and together with GAIL in the joint venture, we're planning to build up to 2 new plants. CapEx will be lower, and so will the production numbers. So India is — the biogas market is taking off.
Claus Sauter
executiveOkay, if I've got the question right, then yes, we're currently seeing strong margins on fossil diesel because of supply problems; however, that has no impact on our biodiesel margin. I attempted to clarify that the biodiesel margin is elevated and has been elevated because rapeseed oil was available, alternatives were lacking, and there were logistical difficulties, with low water levels in the Rhine. So at this point, what happens in 2027 is genuinely difficult to predict; but as I mentioned during my presentation, a great deal of feedstock is disappearing in 2027, all the palm-related material, palm oil, palm oil mill affluents. And our view is that margins, particularly for RME, will continue to be high. That's what we expect. As you know, our guidance is conservative, but let's watch how things develop. 2027 will truly be an interesting situation, with a much greater obligation and less optionality on the biodiesel side.
Claus Sauter
executiveOlaf?
Olaf Troeber
executiveAs Claus said earlier, the key thing is this — what information do we have at this point? We have Q1, and we have that Q2 began with fairly solid margins in the biodiesel segment as well. What we don't have, though, is knowledge of how the term contracts for next year will be finalized, how those margins will develop, et cetera. So yes, as Claus actually put it at the close of this year — at the end of this calendar year, in December or January — we'll have clearer visibility into our margins for the second half; so yes, there's really nothing more to add. We'll provide an update the moment we gain clearer visibility.
Claus Sauter
executiveSo in Nevada, U.S. utilization is sitting at roughly 60%, 70% at the moment. I mentioned there were a few problems with biogas production, though we managed to get some digestate out and get that under control. So we're now ramping up toward full capacity, and it's the same story in South Bend. Utilization there is around 70%; we had some trouble with the dryers in spring 2026, we've been working on that, and now we can keep moving forward there. And we began — this ties into the investment question — we've now started building the biogas plant. I believe 6 or 8 are already built. Our strategy here is that, tied to 45C, we'll burn the crude gas in our boiler, replace natural gas, and generate tax credits through 45C. That's a very attractive option we have now in connection with 45C, which wasn't the case at the original price. So our investment is lower — and I don't know, Olaf, what the plan amounts to, how much we're — I think it's something around $30 million for the South Bend investment in 2027.
Olaf Troeber
executiveYeah, that's right. It's roughly $30 million.
Claus Sauter
executiveSo at the moment, our main goal is still to stay firm on investments. We have our assets there; most of the production in the U.S. isn't fully utilized — not gas, not ethanol — there's some free capacity at different sites; in Europe, the clear aim on one hand is to raise that utilization, and the second thing is to complete our strategy and our ideas there in North America. Canada is a good example. With this new regulation, it's quite fun. Now in the summer, almost every month, we had new record production, and now we can also put a focus there. I think it was highly necessary that Canada is doing its own biofuel policy, and with the CFR, which strongly promotes and supports local production, that also helps. So that's the focus — not big additional investments to get the assets, but the assets we have to higher utilization, and let's make money.
Claus Sauter
executiveYes, I can answer that. Commissioning work at the plant continues; the process is indeed a complicated one. It will take some time, and we expect to have the first sale-level products by the end of November or in December. Right now crude oil prices are high, and crude oil is essential here because of the chemistry involved — there's no obligation, so we must remain competitive. Still, with the products we're making at present, it's interesting. Clients are waiting for product. As I said, in December we expect the first salable volumes. But don't expect too much from this ethanol — for us, this is a project for the future. I believe I mentioned this as well at our Capital Markets Day: should this succeed, and should we manage to provide rapeseed methyl ester for chemical products, incorporated into chemical products and delivered to the market, then I find it hard to picture that such a large volume of biodiesel — such a large volume of RME, rapeseed methyl ester — would still go into biodiesel use going forward, since the margins on the chemical side are considerably larger. Still, it will require time. It will require years. Yet this is truly something fundamental. At the moment, funding a fresh market is within our means, since provided we are able to move our rapeseed methyl ester into the marketplace as biodiesel while demand stays strong, this is the proper moment to establish that new market.
Claus Sauter
executiveAll right, thank you so much. I really appreciate everyone who posed questions, and I hope our responses came across as sensible. We got off to a solid start this year, and the government has plainly done much better than was the case 12 months back. We’re also noticing a shift in the political and regulatory climate. Biofuels are drawing increased attention once more, and steps targeting crops are heading the right way. The elimination of double counting mattered a great deal, since the bulk of product entering Europe didn’t qualify for double counting; that period was genuinely tough for us. Thankfully it’s now behind us; uncertainties certainly remain, and we’ll need to watch how certain of these markets evolve across the months ahead. Still, on the whole we sit in a far stronger place than we did a year ago. So many thanks to everyone who joined. Have a good day.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Verbio SE transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Verbio SE earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Verbio SE or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.